Pharmacovigilance
Pharmacovigilance (PV) is responsible for monitoring the safety of all medical products from the early stages of their development (including early research phases), throughout their entire life cycle, and right up to the point of their commercialization stage. It involves the detection, assessment, understanding, and prevention of any adverse effects that may occur with the use of the drugs.
Any drug product has the potential to trigger adverse events, even those that have undergone extensive development, research, or long periods of commercialization and that comply with rigorous quality standards.
PV is the responsibility of the prescribing physician, the pharmaceutical industry, health authorities, and patients. All pharmacovigilance activities promote the rational and safe use of medical products for the benefit of public health.
Definition of adverse event:
An adverse event is any undesirable experience associated with the use of a medical product in a patient. An adverse event may therefore be any unfavorable and unintended sign or symptom temporarily associated with the use of a medical product, whether or not it is considered related to said product.
Therefore, we invite you to contact us if you have any questions regarding the safety of our products. Any report of adverse events, even if they are known, may help identify potential issues related to the safety of the medical products.
To report an adverse event, please complete the following information:
The information provided will be strictly confidential.
Contact: 0800 333 5658.
Email: farmacovigilancia@roemmers.com.ar
